Cargando…
Could live attenuated vaccines better control COVID-19?
In an effort to control the COVID-19 pandemic, large-scale vaccination is being implemented in various countries using anti-SARS-CoV-2 vaccines based on mRNAs, adenovirus vectors, and inactivated viruses. However, there are concerns regarding adverse effects, such as the induction of fever attribute...
Autores principales: | Okamura, Shinya, Ebina, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354792/ https://www.ncbi.nlm.nih.gov/pubmed/34426024 http://dx.doi.org/10.1016/j.vaccine.2021.08.018 |
Ejemplares similares
-
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
por: Yoshida, Akiho, et al.
Publicado: (2022) -
Covid-19 vaccine tweak could better tackle today's variants
por: Le Page, Michael
Publicado: (2023) -
Pharmacological Studies in Hospitalized COVID-19 Patients in Belgium: We Could Do Better
por: Hites, Maya, et al.
Publicado: (2022) -
Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?
por: Fidel, Paul L., et al.
Publicado: (2020) -
A highly sensitive NanoLuc-based protease biosensor for detecting apoptosis and SARS-CoV-2 infection
por: Arakawa, Masashi, et al.
Publicado: (2023)